User menu

Defining the prognostic value for galectin-3 in cutaneous melanoma.

Bibliographic reference Vereecken, P ; Ghanem, G ; Morandini, R ; Suciu, S ; van Baren, Nicolas ; et. al. Defining the prognostic value for galectin-3 in cutaneous melanoma.. In: The Journal of International Medical Research, Vol. 35, no. 5, p. 731-732 (2007)
Permanent URL http://hdl.handle.net/2078.1/124173
  1. Liu Fu-Tong, Rabinovich Gabriel A., Galectins as modulators of tumour progression, 10.1038/nrc1527
  2. Califice S, Int J Oncol, 25, 983 (2004)
  3. Prieto V. G., Mourad-Zeidan A. A., Melnikova V., Johnson M. M., Lopez A., Diwan A. H., Lazar A. J.F., Shen S. S., Zhang P. S., Reed J. A., Gershenwald J. E., Raz A., Bar-Eli M., Galectin-3 Expression Is Associated with Tumor Progression and Pattern of Sun Exposure in Melanoma, 10.1158/1078-0432.ccr-06-0758
  4. Vereecken P, Heenen M, Serum Galectin-3 in Advanced Melanoma Patients: A Hypothesis on a Possible Role in Melanoma Progression and Inflammation, 10.1177/147323000603400116
  5. Vereecken Pierre, Debray Charles, Petein Michel, Awada Ahmad, Lalmand Marie-Claude, Laporte Marianne, Van Den Heule Bernard, Verhest Alain, Pochet Roland, Heenen Michel, Expression of galectin-3 in primary and metastatic melanoma: immunohistochemical studies on human lesions and nude mice xenograft tumors, 10.1007/s00403-004-0536-6
  6. Vereecken P., Zouaoui Boudjeltia K., Debray C., Awada A., Legssyer I., Sales F., Petein M., Vanhaeverbeek M., Ghanem G., Heenen M., High serum galectin-3 in advanced melanoma: preliminary results., 10.1111/j.1365-2230.2005.01992.x